- In July 2018 Health Canada licensed the sale and use of Biktarvy for the treatment of HIV infection. Biktarvy, manufactured by Gilead Sciences, is supplied as ...
- When used as part of combination HIV therapy (ART), the class of drugs called integrase inhibitors has potent anti-HIV activity and is generally well tolerated. ...
- In order to redress the legacy of residential schools and advance the process of Canadian reconciliation, the Truth and Reconciliation Commission makes 94 calls to action.
- CATIE NewsPrevious research has found HIV-positive Canadians stop attending follow-up HIV appointments at rates between 11% and 24%.. Alberta researchers find that many ...
- CATIE NewsCanadian expert panel proposes criteria for clinicians to identify individuals who would benefit from PrEP or PEP for HIV prevention.. Guidelines offer ...